Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +0.71% | +6.02% | +5.22% |
Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Neutral |
Resistance | 1.530 | 1.750 | 1.810 |
Spread/Res. | -7.84% | -19.43% | -22.10% |
Spread/Supp. | +7.63% | +7.63% | +39.60% |
Support | 1.310 | 1.310 | 1.010 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PGEN Stock
- Charts Precigen, Inc.